Earnings Call · Q4 FY2024·2025-03-18

Q4 24EPS +6.06%·Rev n/aQ3 24EPS -18.18%·Rev n/aQ2 24EPS -9.09%·Rev n/aQ1 24EPS -22.22%·Rev n/a⚠ consensus missing

Trevi Therapeutics, Inc. TRVI

Jennifer Good — President & CEO

Lisa Delfini — Chief Financial Officer

−1.0%1d on move date−1.1% vs SPY3d−2.0%5d−6.1%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TRVI calls or request research access.

More TRVI calls Browse calls Request research access